Patrick James Orme

Array ( [id] => 5539880 [patent_doc_number] => 20090221685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR THE USE IN MODULATION OF MICRORNAS' [patent_app_type] => utility [patent_app_number] => 12/161286 [patent_app_country] => US [patent_app_date] => 2007-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36539 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221685.pdf [firstpage_image] =>[orig_patent_app_number] => 12161286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4523902 [patent_doc_number] => 07951784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'RNA interference agents for therapeutic use' [patent_app_type] => utility [patent_app_number] => 11/698785 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 25171 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951784.pdf [firstpage_image] =>[orig_patent_app_number] => 11698785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944467 [patent_doc_number] => 20080081793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Oligonucleotide Compositions and Their Use to Induce Apoptosis' [patent_app_type] => utility [patent_app_number] => 11/626614 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6265 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081793.pdf [firstpage_image] =>[orig_patent_app_number] => 11626614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697038 [patent_doc_number] => 20110229552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/161951 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16558 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229552.pdf [firstpage_image] =>[orig_patent_app_number] => 12161951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711473 [patent_doc_number] => 08092819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Implantable medical device coated with a bioactive agent' [patent_app_type] => utility [patent_app_number] => 11/655300 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14550 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/092/08092819.pdf [firstpage_image] =>[orig_patent_app_number] => 11655300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561590 [patent_doc_number] => 20100272722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Therapeutic uses of inhibitors of RTP801' [patent_app_type] => utility [patent_app_number] => 11/655636 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 57577 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272722.pdf [firstpage_image] =>[orig_patent_app_number] => 11655636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188432 [patent_doc_number] => 20070166740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'MULTIPLEXED ANALYSES OF TEST SAMPLES' [patent_app_type] => utility [patent_app_number] => 11/623535 [patent_app_country] => US [patent_app_date] => 2007-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 27387 [patent_no_of_claims] => 121 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166740.pdf [firstpage_image] =>[orig_patent_app_number] => 11623535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114925 [patent_doc_number] => 08158670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Therapeutic inhibitor of vascular smooth muscle cells' [patent_app_type] => utility [patent_app_number] => 11/650059 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 34806 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158670.pdf [firstpage_image] =>[orig_patent_app_number] => 11650059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186896 [patent_doc_number] => 20120115923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment' [patent_app_type] => utility [patent_app_number] => 12/087413 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9775 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115923.pdf [firstpage_image] =>[orig_patent_app_number] => 12087413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4547924 [patent_doc_number] => 07960358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Antisense modulation of stearoyl-CoA desaturase expression' [patent_app_type] => utility [patent_app_number] => 11/613144 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35066 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960358.pdf [firstpage_image] =>[orig_patent_app_number] => 11613144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028919 [patent_doc_number] => 20070270366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'DOUBLE STRANDED NUCLEIC ACID MOLECULES TARGETED TO IL-4 RECEPTOR ALPHA' [patent_app_type] => utility [patent_app_number] => 11/612904 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23065 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270366.pdf [firstpage_image] =>[orig_patent_app_number] => 11612904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534262 [patent_doc_number] => 07888325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA' [patent_app_type] => utility [patent_app_number] => 11/637623 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 12815 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888325.pdf [firstpage_image] =>[orig_patent_app_number] => 11637623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035323 [patent_doc_number] => 20070099862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'siRNA targeting carbonic anhydrase II' [patent_app_type] => utility [patent_app_number] => 11/635618 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 28419 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099862.pdf [firstpage_image] =>[orig_patent_app_number] => 11635618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4978131 [patent_doc_number] => 20070219365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'ENZYMATIC NUCLEIC ACID MOLECULES' [patent_app_type] => utility [patent_app_number] => 11/605177 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27233 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219365.pdf [firstpage_image] =>[orig_patent_app_number] => 11605177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971960 [patent_doc_number] => 20070111963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Modulation of gene expression by oligomers targeted to chromosomal DNA' [patent_app_type] => utility [patent_app_number] => 11/599566 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8462 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111963.pdf [firstpage_image] =>[orig_patent_app_number] => 11599566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253915 [patent_doc_number] => 20070135371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Antisense IAP nucleobase oligomers and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/586554 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21856 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135371.pdf [firstpage_image] =>[orig_patent_app_number] => 11586554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451253 [patent_doc_number] => 07964577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy' [patent_app_type] => utility [patent_app_number] => 12/090191 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 37 [patent_no_of_words] => 31355 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964577.pdf [firstpage_image] =>[orig_patent_app_number] => 12090191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369956 [patent_doc_number] => 07476729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Dbait and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/524528 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16852 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476729.pdf [firstpage_image] =>[orig_patent_app_number] => 11524528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82268 [patent_doc_number] => 07745609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Antisense modulation of CD40 expression' [patent_app_type] => utility [patent_app_number] => 11/466369 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29513 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745609.pdf [firstpage_image] =>[orig_patent_app_number] => 11466369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515556 [patent_doc_number] => 20090215863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Gene Silencing of Protease Activated Receptor 1(Par1)' [patent_app_type] => utility [patent_app_number] => 11/990512 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7336 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215863.pdf [firstpage_image] =>[orig_patent_app_number] => 11990512 [rel_patent_id] =>[rel_patent_doc_number] =>)